Navigation Links
Echo Therapeutics to Present at the JMP Securities Healthcare Conference
Date:9/23/2010

FRANKLIN, Mass., Sept. 23 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present at the JMP Securities Healthcare Conference being held September 27-28, 2010 at the New York Palace Hotel, 455 Madison Avenue, New York, NY. The Company's presentation is scheduled for 4:30 p.m. ET on September 27, 2010 in the Kennedy I room. Management will be available during the day on September 27 for one-on-one meetings. Please contact your JMP Securities representative to schedule a meeting.

Dr. Mooney will discuss progress of the Company's robust technology platform. Echo Therapeutics recently announced the successful completion of a clinical study to evaluate the ability of Prelude to ablate the skin prior to the application of OTC 4% lidocaine cream for faster-acting local dermal anesthesia. In addition, Echo recently completed the initial product development work on its Prelude SkinPrep System and the Company is now focused on completing the final steps of its regulatory advance to commercialization and leveraging its key strategic partnerships to generate product-related revenue.

About JMP SecuritiesJMP Securities is a full-service investment bank that provides equity research, institutional brokerage and investment banking services to public and private growth companies and their investors. The firm is a subsidiary of publicly traded JMP Group Inc. (NYSE: JMP).

About Echo TherapeuticsEcho is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

Cautionary Statement Regarding Forward Looking StatementsThe statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's and its partners' ongoing studies, including the efficacy of Echo's Symphony tCGM and Prelude SkinPrep Systems, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM and Prelude SkinPrep Systems, Echo's ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo's and its partners' ability to develop, market and sell diagnostic and transdermal drug delivery products based on its skin permeation platform technologies, including the Symphony tCGM and Prelude SkinPrep Systems, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its Symphony tCGM and Prelude SkinPrep Systems. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K for the year ended December 31, 2009, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. Echo undertakes no obligation to publicly update or revise any forward-looking statements.For More Information:Patrick T. Mooney, M.D.

Jeffrey Stanlis

Media: Richard Stern Chairman and Chief Executive Officer

Partner, Hayden IR

Stern & Co.(508) 530-0329

(602) 476-1821

(212) 888-0044
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award
2. Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring
3. Signum Biosciences Awarded Two Additional NIH Grants for Development of Topical Therapeutics
4. CoDa Therapeutics NEXAGON® Wound Healing Gel Named to Windhovers Top 10 HOT SPACE Projects to Watch
5. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
6. Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference
7. Arcion Therapeutics Receives FDA Fast Track Designation for ARC-4558 for the Treatment of Pain Associated with Painful Diabetic Neuropathy
8. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
9. Halozyme Therapeutics Announces Public Offering of Common Stock
10. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
11. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , February 22, 2017 Arthroscopy Devices Market Report, published by ... 2015 and is projected to reach $5,334 million by 2022, growing at a CAGR ... the total market in 2015. Continue Reading ... ... ...
(Date:2/22/2017)...  Known for selling everyday household products commonly ... prominent California urologist Dr. ... about the British conglomerate that makes those products – ... steal her late husband,s invention, business plans, and other ... Gilbert until his violent death in 2013, filed suit ...
(Date:2/22/2017)... , February 22, 2017 A research ... North America and the continuously changing landscape of ... in 2016 in the North America , a ... to increase to $21.6 billion by the year 2021 representing a ... the United States and Canada ...
Breaking Medicine Technology:
(Date:2/22/2017)... Los Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... medical detox treatment to the thousands of individuals who have recently fallen victim to ... accredited hospital in Orange County, California, where they are free from the shame, ...
(Date:2/22/2017)... ... , ... South Bend’s Lunkerville, the award-winning TV series that catches real people ... (HOW), a non-profit organization dedicated to helping military veterans relax, rehabilitate, and reintegrate through ... to Lake Denmark, New Jersey, to fish with war veteran Justin Vail from the ...
(Date:2/22/2017)... ... February 22, 2017 , ... In ... reported skipping doses or not filling a prescription because they could not afford ... cost-related problems getting medications were 30-60%*. At the same time, hospitals, ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World Horse ... host Tom Seay and his production crew. Tom Seay’s program “Best of America ... world. Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, ...
(Date:2/22/2017)... D.C. (PRWEB) , ... February 22, 2017 , ... ... being celebrated throughout the country today, as organizations, advocates, and individuals join together ... detection and treatment access to ultimately save lives. , “Today we mark a ...
Breaking Medicine News(10 mins):